Prisons and HCV: a review and a report on an experience in New South Wales Australia.

摘要: Prison populations in Western countries are characterised by a high hepatitis C prevalence. This reflects rate of imprisonment for drug related offences. entrants who HCV‐negative face significant risk acquiring C. Effective prevention strategies and successful treatment percentage C‐positive inmates could reduce the transmission prison context significantly. Several reports treating prisoners major facilities have been published. We report our experience establishing liver clinic service two regional prisons New South Wales, Australia. Liver biopsy requirements to access Australia meant that only 46 196 reviewed patients were able commence 5‐year experience. Treatment completion was 61% end viral response 57%. The removal April 2006 has freed up results encourage further effort optimise process assessment this high‐risk population.